← Evidence map

ArticlePharmaceutical medicine2026

Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation.

Jeremy A Bartlett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

6 trials

Full record →Abstract, authors, funding and every citing paper · PMID 41920422